Indo Us Bio-Tech Ltd. submitted a revised disclosure under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 (Regulation 30) to clarify the effective date of committee reconstitution.
The company informs that pursuant to the appointment and resignation of Directors approved by the Board at its meeting held on 21 April 2026, the composition of the Committees of the Board stood reconstituted with effect from 21 April 2026, not 10 July 2026 as previously reported.
The revised committee compositions are as follows:
Audit Committee
- Ritaben Nileshbhai Kikani - Chairperson
- Shilpa Chetanbhai Thumar - Member
- Jagdishkumar Devjibhai Ajudiya - Member
- Hemanshi Darsh Soni - Member
Nomination and Remuneration Committee
- Shilpa Chetanbhai Thumar - Chairperson
- Ritaben Nileshbhai Kikani - Member
- Hemanshi Darsh Soni - Member
Stakeholders Relationship Committee
- Ritaben Nileshbhai Kikani - Chairperson
- Jagdishkumar Devjibhai Ajudiya - Member
- Hemanshi Darsh Soni - Member
- Shilpa Chetanbhai Thumar - Member
Except for this clarification regarding the effective date of the reconstitution of the Committees, all other disclosures and contents of the Outcome of the Board Meeting dated 10 July 2026 remain unchanged.
The disclosure was signed by Dimpy Divyangbhai Joshi, Company Secretary & Compliance officer, on 15 July 2026 at 16:08:59 IST.